The Mycobacterial Cell Wall: Structure, Function and Biosynthesis
The Mycobacterial Cell Wall: Structure, Function and Biosynthesis
批准号:
G0500590/1
负责人:
Gurdyal Besra
金额:
$55.04万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Tuberculosis (TB) is a life?threatening condition that can last for several years during which patients are debilitated and may disseminate the bacterium that causes the disease, Mycobacterium tuberculosis (Mtb). At least 30 million individuals worldwide will have died from TB in the last decade of the 20th century. In the UK the steady decline in TB cases over the whole of the last century halted in the mid 1980s and there has been alarming signs of increased numbers of cases in certain communities. The situation is compounded by the AIDS epidemic and by the emergence of Mtb strains that are resistant to virtually all the drugs that would normally be used to treat TB. It can be argued that, globally, Mtb is the single most important infectious agent affecting mankind. All bacteria have cells that, like plants, are enclosed in a cell wall. This protects the organism from its immediate environment and, fortuitously, presents an important target for drugs, like penicillin, that can be used to treat bacterial infections. However, Mtb has a distinctive cell wall that differs in composition from that of other bacteria; in particular it contains an exceptional amount of unique lipids (fats) and sugars. Although there are drugs that affect the unique Mtb cell wall, the current treatment for tuberculosis lasts 6 months and is potentially toxic to patients who often cease treatment early. Moreover, the efficacy of treatment is threatened by the emergence of drug-resistant strains of Mtb. There is therefore a great need for new and better drugs to treat TB. Communication to the general public will be channelled through the University Press Office at Birmingham (http://www.newscentre.bham.ac.uk/office.htm) which has established contacts in the local and national media. The MRC Co-operative Group members will also highlight there research through personal University based Web pages, which has open access. This highlights the clinical and research elements of the MRC Co-operative Group.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Mycobacterium tuberculosis Cell Envelope: unravelling complex cell wall assembly, degradation and re-cycling pathways
-
批准号:MR/S000542/1
-
项目类别:Research Grant
-
资助金额:$219.27万
-
财政年份:2019
-
负责人:Gurdyal Besra
-
依托单位:
MICA: Addressing the burgeoning problem of tuberculosis: Exploiting phenotypic hits to identify new protein targets for drug discovery
-
批准号:MR/R001154/1
-
项目类别:Research Grant
-
资助金额:$115.59万
-
财政年份:2018
-
负责人:Gurdyal Besra
-
依托单位:
Dissecting the role of mycobacterial cell envelope components and DNA in leprosy reactions
-
批准号:MR/N017420/1
-
项目类别:Research Grant
-
资助金额:$41.63万
-
财政年份:2016
-
负责人:Gurdyal Besra
-
依托单位:
The Mycobacterium tuberculosis Cell Envelope: unravelling complex cell wall assembly and the identification of potential new drug targets
-
批准号:MR/K012118/1
-
项目类别:Research Grant
-
资助金额:$185.45万
-
财政年份:2013
-
负责人:Gurdyal Besra
-
依托单位:
Design, synthesis, and assessment of specific iNKT cell agonists for clinical applications
-
批准号:G1001750/1
-
项目类别:Research Grant
-
资助金额:$121.89万
-
财政年份:2012
-
负责人:Gurdyal Besra
-
依托单位:
The biochemical characterisation of pivotal enzymes involved in mycobacterial peptidoglycan biosynthesis
-
批准号:G1001023/1
-
项目类别:Research Grant
-
资助金额:$77.7万
-
财政年份:2011
-
负责人:Gurdyal Besra
-
依托单位:
Biochemical characterisation of pivotal enzymes involved in mycobacterial mycolic acid biosynthesis
-
批准号:G0901327/1
-
项目类别:Research Grant
-
资助金额:$51.51万
-
财政年份:2010
-
负责人:Gurdyal Besra
-
依托单位:
Mycobacterium tuberculosis capsular alpha-glucan biosynthesis and characterisation of host-pathogen interactions
-
批准号:G0901690/1
-
项目类别:Research Grant
-
资助金额:$50.55万
-
财政年份:2010
-
负责人:Gurdyal Besra
-
依托单位:
MAGPIE Project: The Structure, Biosynthesis and Assembly of the Mycobacterial Cell Envelope
-
批准号:G9901077-E02/2
-
项目类别:Research Grant
-
资助金额:$42.11万
-
财政年份:2006
-
负责人:Gurdyal Besra
-
依托单位:
国内基金
海外基金
登录
查看更多内容
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
-
批准号:QN25H220002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:顾媛
-
依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王锐智
-
依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位:
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
-
批准号:82305053
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王丽明
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
-
批准号:82373069
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:何美芳
-
依托单位:
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:宋贾俊
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:51万元
-
批准年份:2022
-
负责人:黄红艳
-
依托单位:
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
-
批准号:2021JJ30609
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:肖勇健
-
依托单位: